The results of this study indicated that high-grade DCIS cases with low PR levels (< 20%) combined with high Ki67 expression (≥ 20%) were more likely to be of the HER2-enriched subtype (p < 0.0001, chi-squared test) (Figure 5). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.